macrocyclic peptide complement inhibitor
Zilucoplan dose
Answer
FDA label for ZILBRYSQ: The recommended dosage of ZILBRYSQ is given once daily as a subcutaneous injection and is dependent on actual body weight (see Table 1 ). Trials with posted results tested 1 dose, most often 0.3 mg/kg.
Not dosing advice.
FDA LABEL
What the approved labels state
ZILBRYSQ NDA216834 · label of 2026-02-03 Regulator
The recommended dosage of ZILBRYSQ is given once daily as a subcutaneous injection and is dependent on actual body weight (see Table 1 ).
IN TRIALS
Doses tested in 12 trials with posted results
| Dose in the arm title | Trials | People on it | Phases |
|---|---|---|---|
| 0.3 mg/kg | 3 | 137 | 2/3 |
Trial register Read from the titles of arms that received Zilucoplan (n ≥ 20). An arm naming several doses counts under each; a schedule or escalation is on the trial record. All trials.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.